Emtricitabine Cyclic-III impurity

Emtricitabine Cyclic-III impurity is a structurally related degradation product formed via intramolecular cyclization of the parent nucleoside. It retains the 1,3-dioxolane sugar core fused to a cyclopropyl group but features a five-membered cyclic ether linkage at the 2'-cyanovinyl moiety, replacing the linear acyclic configuration of Emtricitabine. This cyclic transformation introduces a rigid conformational constraint, altering hydrogen bonding potential and hydrophobic interactions. The compound serves as a critical HPLC reference standard for quantifying process-related impurities in Emtricitabine bulk drug substance synthesis.